Drug recall
Endometrin (progesterone) Vaginal Insert 100mg, packaged in a carton of 21 vaginal inserts with 21 disposable…
FDA recall event 92494 · Class II · Ferring Pharmaceuticals Inc
Key facts
| Event ID | 92494 |
|---|---|
| Recall numbers | D-0879-2023 |
| Recalling firm | Ferring Pharmaceuticals Inc |
| Product type | Drugs |
| Products | Endometrin (progesterone) Vaginal Insert 100mg, packaged in a carton of 21 vaginal inserts with 21 disposable vaginal applicators, Manufactured for: Ferring Pharmaceuticals Inc., Parsippany, NJ NDC#… |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | cGMP deviations: potential for Microbial Contamination of Non-Sterile Products |
| Initiation date | Jun 12, 2023 |
| Report date | Jul 5, 2023 |
| Termination date | Aug 5, 2024 |
| City | Parsippany |
| State | NJ |
| Country | United States |
| FEI number | 1000119907 |
At a glance
- 1–9 Products in this recall
- None FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: